Ranolazine (add‐on therapy) vs placebo
All‐cause mortality · patients with stable angina pectoris
Ranolazine (add‐on therapy) showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
- RR 0.83 [0.26, 2.71]3 studies · 2053 participantsLow